{
  "title": "Double agents and drug discounts",
  "description": "The cost of pharmaceuticals has been rising for years, well before inflation became the big economic talking point. Today on the show, why some policymakers suspect an obscure middleman is partly to blame.",
  "pubDate": "Tue, 09 Aug 2022 21:34:40 -0400",
  "copyright": "Copyright 2015-2021 NPR - For Personal Use Only",
  "guid": "c966ca63-febd-4e5d-855e-e547b502af35",
  "link": "https://www.npr.org/2022/08/09/1116670946/double-agents-and-drug-discounts",
  "itunes:title": "Double agents and drug discounts",
  "itunes:episode": 1167,
  "itunes:author": "NPR",
  "itunes:summary": "The cost of pharmaceuticals has been rising for years, well before inflation became the big economic talking point. Today on the show, why some policymakers suspect an obscure middleman is partly to blame.",
  "itunes:image": "",
  "itunes:duration": 599,
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "content:encoded": "The cost of pharmaceuticals has been rising for years, well before inflation became the big economic talking point. Today on the show, why some policymakers suspect an obscure middleman is partly to blame.",
  "enclosure": ""
}